Covista Inc. (CVSA)
| Market Cap | 4.31B-12.0% |
| Revenue (ttm) | 1.95B |
| Net Income | 267.38M |
| EPS | 7.49 |
| Shares Out | 33.86M |
| PE Ratio | 17.00 |
| Forward PE | 12.72 |
| Dividend | n/a |
| Ex-Dividend Date | Nov 30, 2016 |
| Volume | 267,286 |
| Open | 128.00 |
| Previous Close | 127.37 |
| Day's Range | 126.58 - 128.97 |
| 52-Week Range | 86.97 - 156.26 |
| Beta | 0.65 |
| Analysts | Buy |
| Price Target | 158.75(+24.71%) |
| Earnings Date | Oct 29, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About CVSA
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CVSA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CVSA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CVSA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CVSA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CVSA Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Tuition and fees | $1.95B | 49.77% |
| Walden | $804.93M | 20.60% |
| Chamberlain | $750.21M | 19.20% |
| Medical and Veterinary | $398.94M | 10.21% |
| Other | $8.89M | 0.23% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-K)
U.S. Patents
New CVSA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CVSA from public contracts
Source: USAspending.gov
CVSA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CVSA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score